All News

Just 24.7% of elderly patients with chronic obstructive pulmonary disease (COPD) included in the study demonstrated correct usage of their inhaler.

As employers seek to gain a pulse of what the health care benefit cost trend will be for the coming year, the Business Group on Health will be monitoring several factors, including the impact of the pandemic, efficacy of virtual care, and deferral in care delivery.

Researchers found the nucleocapsid protein (NP) antigen of SARS-CoV-2, the virus which causes coronavirus disease 2019 (COVID-19), existed intracellularly in the ocular tissues of a patient who previously had COVID-19.

An editorial criticizes the administration’s response to coronavirus disease 2019 (COVID-19); the National Cancer Institute announces an antibody testing network; 39 states see rises in COVID-19 cases.

Blythe Adamson, PhD, MPH, of Flatiron Health, discusses study results she presented at the annual American Society of Clinical Oncology meeting on the use of immune checkpoint inhibitors in end-of-life care

The future of migraine research will include further investigations into understanding the pathophysiology of migraine outside of CGRP, said Frank Porreca, PhD, professor of pharmacology and anesthesiology at the University of Arizona and a member of the Department of Collaborative Research at Mayo Clinic in Arizona.

Results showed variation by age, gender, and partisan affiliation. But there's agreement on the need to lower the cost of prescription drugs.

Patients hospitalized for acute heart failure during the coronavirus disease 2019 (COVID-19) pandemic had more advanced disease and were more symptomatic, according to study results out of Australia.

In an attempt to develop a multivariable predictive model for days with new-onset migraine headaches, researchers found episodic migraine attacks were not predictable based on self-prediction or on self-reported exposure to common trigger factors.

Migraine prevention helps drive down functional disability among migraineurs, said Peter McAllister, MD, a neurologist, board certified headache specialist, and medical director of the New England Institute for Neurology and Headache.

Two women are awarded the Nobel Prize in Chemistry for CRISPR; Eli Lilly partners with DexCom, Inc; the US arm of AstraZeneca’s coronavirus disease 2019 (COVID-19) vaccine trial remains halted.

More Humana doctors are taking on full global risk under Medicare Advantage than are still using traditional fee-for-service.

Because patients with chronic migraine experience more monthly migraine days (MMD) than those with episodic migraine, chronic migraineurs will experience a greater reduction of MMD with erenumab, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

At a session Tuesday at the Migraine Trust International Symposium, one presentation delved into findings published this year in medication overuse headaches, prevention, and pathophysiology of migraine as well as cluster headaches.

In this episode of Managed Care Cast, we speak with a male patient with breast cancer who was diagnosed with metastatic disease in 2016 about how he lives his life and what he wants people to know about this rare cancer.

In this study from Cape Town, South Africa, patients with comorbid HIV and a history of mental illness had an increased risk of mortality from all causes.

Researchers examine the clinical and pathophysiological mechanisms underlying pain in Parkinson disease.

Racial disparities in insulin pump use among children with type 1 diabetes (T1D) have persisted over the past 15 years, independent of socioeconomic status.

Treatment guidelines for comorbid depression and migraine are warranted to ensure optimal efficacy and avoid possible pitfalls in psychopharmacotherapy, according to study results.

Medication overuse headache is a peculiar disorder where the cure becomes the cause, said Rigmor Jensen, MD, professor of neurology at The University of Copenhagen and director of the Danish Headache Center.

The CDC confirms that SARS-CoV-2 can be spread via airborne particles; the White House blocks new FDA guidelines on bringing potential vaccines to market; the Supreme Court will hear a case on pharmacy benefit managers.

Telehealth claims peaked in June 2020, then eased off a bit in July. There were more telehealth claims in the Northeast than in other regions.

Oxymetazoline, 0.1% may hold potential as a promising treatment option for individuals with acquired blepharoptosis, according to results of a pooled analysis published in JAMA Ophthalmology.

Personalized recommendations for patients with non–small cell lung cancer with squamous histology could benefit from research on treatment choice and biomarkers, noted Blythe Adamson, PhD, MPH, principal quantitative scientist at Flatiron Health.

Compared with 2018 and 2019, data from 2020 show reports of headache frequency increased, despite decreases in reports of the 4 most common migraine triggers, said Faraidoon Haghdoost, MD, a general practitioner and PhD student at The George Institute for Global Health in Sydney, Australia.

Research from the American Cancer Society suggests that more young people are being introduced to nicotine via e-cigarettes.

About 3 days after being airlifted to the hospital to be treated for symptoms stemming from coronavirus disease 2019 (COVID-19) infection, the president is returning to the White House.

Targeted tumor delivery of irinotecan through sacituzumab govitecan can help to reduce treatment-related toxicities, noted Timothy A. Yap, MBBS, PhD, FRCP, medical director of the Institute for Applied Cancer Science, MD Anderson Cancer Center.